Steve Bubrick's Colleagues at Insulet Corporation
Deborah Gordon
Vice President, Investor Relations and Corporate Communications
Paul Holton
Vice President, Financial Planning & Analysis, Commercial & Strategy
Steve Bubrick's Contact Details
978-600-7000
Insulet Corporation
Steve Bubrick's Company Details
Insulet Corporation (Insulet or the Company), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod® Insulin Management System (Omnipod System) provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. Founded in 2000 (NASDAQ: PODD), Insulet operates with a customer-centric focus to supply high-quality products and expand the use of insulin pump therapy. Omnipod products are now available in 21 countries around the globe.